Walgreens’ massive $6 billion healthcare gamble has spectacularly collapsed, leaving hundreds of primary care clinics up for sale.
Story Snapshot
- Sycamore Partners completed $10 billion Walgreens acquisition, immediately putting VillageMD’s hundreds of clinics on the market
- Walgreens lost over $8 billion on its primary care bet, forcing complete abandonment of healthcare expansion strategy
- VillageMD operates 465+ locations including Village Medical, CityMD, Summit Health, and Starling Physicians practices nationwide
- Private equity takeover signals end of retail pharmacy’s ambitious push into direct patient care delivery
Private Equity Cleans Up Healthcare Disaster
Sycamore Partners completed its $10 billion acquisition of Walgreens Boots Alliance in August 2025, immediately moving to offload the company’s catastrophic healthcare investments. VillageMD now operates as a standalone entity under Sycamore’s control, actively seeking buyers for its extensive network of primary care facilities. The private equity firm aims to maximize asset value while cutting mounting operational losses that have plagued Walgreens for years.
Walgreens Boots Alliance $WBA is officially private and will cease to exist as a vertically integrated business as Sycamore Partners closed its deal to acquire the retail pharmacy giant on Thursday.
The chain has been around 124 years. pic.twitter.com/pIpUDgerxc
— Cole Grinde (@GrindeOptions) August 28, 2025
Billion-Dollar Healthcare Blunder Unfolds
Walgreens’ healthcare ambitions began in 2019 with pilot clinics in Houston, rapidly expanding through a $5.2 billion investment in 2021 that made it VillageMD’s majority owner. The company planned 500-700 Village Medical locations over five years, positioning itself as a leader in retail-based primary care. However, slower-than-expected patient growth, Medicare reimbursement changes, and operational inefficiencies destroyed the business model’s viability.
Georgetown University analyst Sandeep Dahiya estimates VillageMD’s current value at only $1 billion, far below Walgreens’ $3.4 billion expectations. The company reported over $8 billion in net losses by 2024, largely attributed to its VillageMD investment. This financial catastrophe forced CEO Tim Wentworth to abandon the healthcare strategy entirely, focusing resources back on core pharmacy operations.
Watch: Walgreens agrees to be acquired by private equity firm for almost $10 billion
Massive Asset Sale Threatens Patient Access
VillageMD’s fire sale includes over 130 Village Medical practices, with 90 located adjacent to Walgreens stores, plus 185 CityMD clinics, 130 Summit Health locations, and 20+ Starling Physicians practices. This massive divestiture creates uncertainty for thousands of patients who rely on these facilities for primary care services. The closures particularly impact underserved communities where VillageMD clinics often provided convenient, accessible healthcare options.
Industry experts warn that private equity ownership typically leads to aggressive cost-cutting measures that could further reduce care quality and accessibility. Healthcare economists highlight the risks of rapid expansion without sufficient patient demand, noting that Walgreens’ failure may deter other retailers from similar healthcare ventures, potentially limiting future competition and innovation in primary care delivery.
Sources:
Walgreens exploring options for VillageMD business, including selling entire stake – Fierce Healthcare
Walgreens Boots Alliance makes $5.2 billion investment in VillageMD – VillageMD Press Release
Walgreens move to go private: 4 key takeaways – American Hospital Association
WBA definitive agreement acquired by Sycamore Partners – Walgreens Press Release
